Cargando…

Hemagglutinin-specific neutralization of subacute sclerosing panencephalitis viruses

Subacute sclerosing panencephalitis (SSPE) is a progressive, lethal complication of measles caused by particular mutants of measles virus (MeV) that persist in the brain despite high levels of neutralizing antibodies. We addressed the hypothesis that antigenic drift is involved in the pathogenetic m...

Descripción completa

Detalles Bibliográficos
Autores principales: Muñoz-Alía, Miguel Ángel, Muller, Claude P., Russell, Stephen J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5821319/
https://www.ncbi.nlm.nih.gov/pubmed/29466428
http://dx.doi.org/10.1371/journal.pone.0192245
_version_ 1783301495270146048
author Muñoz-Alía, Miguel Ángel
Muller, Claude P.
Russell, Stephen J.
author_facet Muñoz-Alía, Miguel Ángel
Muller, Claude P.
Russell, Stephen J.
author_sort Muñoz-Alía, Miguel Ángel
collection PubMed
description Subacute sclerosing panencephalitis (SSPE) is a progressive, lethal complication of measles caused by particular mutants of measles virus (MeV) that persist in the brain despite high levels of neutralizing antibodies. We addressed the hypothesis that antigenic drift is involved in the pathogenetic mechanism of SSPE by analyzing antigenic alterations in the MeV envelope hemagglutinin protein (MeV-H) found in patients with SSPE in relation to major circulating MeV genotypes. To this aim, we obtained cDNA for the MeV-H gene from tissue taken at brain autopsy from 3 deceased persons with SSPE who had short (3–4 months, SMa79), average (3.5 years, SMa84), and long (18 years, SMa94) disease courses. Recombinant MeVs with a substituted MeV-H gene were generated by a reverse genetic system. Virus neutralization assays with a panel of anti-MeV-H murine monoclonal antibodies (mAbs) or vaccine-immunized mouse anti-MeV-H polyclonal sera were performed to determine the antigenic relatedness. Functional and receptor-binding analysis of the SSPE MeV-H showed activity in a SLAM/nectin-4–dependent manner. Similar to our panel of wild-type viruses, our SSPE viruses showed an altered antigenic profile. Genotypes A, G3, and F (SSPE case SMa79) were the exception, with an intact antigenic structure. Genotypes D7 and F (SSPE SMa79) showed enhanced neutralization by mAbs targeting antigenic site IIa. Genotypes H1 and the recently reported D4.2 were the most antigenically altered genotypes. Epitope mapping of neutralizing mAbs BH015 and BH130 reveal a new antigenic site on MeV-H, which we designated Φ for its intermediate position between previously defined antigenic sites Ia and Ib. We conclude that SSPE-causing viruses show similar antigenic properties to currently circulating MeV genotypes. The absence of a direct correlation between antigenic changes and predisposition of a certain genotype to cause SSPE does not lend support to the proposed antigenic drift as a pathogenetic mechanism in SSPE.
format Online
Article
Text
id pubmed-5821319
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-58213192018-03-02 Hemagglutinin-specific neutralization of subacute sclerosing panencephalitis viruses Muñoz-Alía, Miguel Ángel Muller, Claude P. Russell, Stephen J. PLoS One Research Article Subacute sclerosing panencephalitis (SSPE) is a progressive, lethal complication of measles caused by particular mutants of measles virus (MeV) that persist in the brain despite high levels of neutralizing antibodies. We addressed the hypothesis that antigenic drift is involved in the pathogenetic mechanism of SSPE by analyzing antigenic alterations in the MeV envelope hemagglutinin protein (MeV-H) found in patients with SSPE in relation to major circulating MeV genotypes. To this aim, we obtained cDNA for the MeV-H gene from tissue taken at brain autopsy from 3 deceased persons with SSPE who had short (3–4 months, SMa79), average (3.5 years, SMa84), and long (18 years, SMa94) disease courses. Recombinant MeVs with a substituted MeV-H gene were generated by a reverse genetic system. Virus neutralization assays with a panel of anti-MeV-H murine monoclonal antibodies (mAbs) or vaccine-immunized mouse anti-MeV-H polyclonal sera were performed to determine the antigenic relatedness. Functional and receptor-binding analysis of the SSPE MeV-H showed activity in a SLAM/nectin-4–dependent manner. Similar to our panel of wild-type viruses, our SSPE viruses showed an altered antigenic profile. Genotypes A, G3, and F (SSPE case SMa79) were the exception, with an intact antigenic structure. Genotypes D7 and F (SSPE SMa79) showed enhanced neutralization by mAbs targeting antigenic site IIa. Genotypes H1 and the recently reported D4.2 were the most antigenically altered genotypes. Epitope mapping of neutralizing mAbs BH015 and BH130 reveal a new antigenic site on MeV-H, which we designated Φ for its intermediate position between previously defined antigenic sites Ia and Ib. We conclude that SSPE-causing viruses show similar antigenic properties to currently circulating MeV genotypes. The absence of a direct correlation between antigenic changes and predisposition of a certain genotype to cause SSPE does not lend support to the proposed antigenic drift as a pathogenetic mechanism in SSPE. Public Library of Science 2018-02-21 /pmc/articles/PMC5821319/ /pubmed/29466428 http://dx.doi.org/10.1371/journal.pone.0192245 Text en © 2018 Muñoz-Alía et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Muñoz-Alía, Miguel Ángel
Muller, Claude P.
Russell, Stephen J.
Hemagglutinin-specific neutralization of subacute sclerosing panencephalitis viruses
title Hemagglutinin-specific neutralization of subacute sclerosing panencephalitis viruses
title_full Hemagglutinin-specific neutralization of subacute sclerosing panencephalitis viruses
title_fullStr Hemagglutinin-specific neutralization of subacute sclerosing panencephalitis viruses
title_full_unstemmed Hemagglutinin-specific neutralization of subacute sclerosing panencephalitis viruses
title_short Hemagglutinin-specific neutralization of subacute sclerosing panencephalitis viruses
title_sort hemagglutinin-specific neutralization of subacute sclerosing panencephalitis viruses
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5821319/
https://www.ncbi.nlm.nih.gov/pubmed/29466428
http://dx.doi.org/10.1371/journal.pone.0192245
work_keys_str_mv AT munozaliamiguelangel hemagglutininspecificneutralizationofsubacutesclerosingpanencephalitisviruses
AT mullerclaudep hemagglutininspecificneutralizationofsubacutesclerosingpanencephalitisviruses
AT russellstephenj hemagglutininspecificneutralizationofsubacutesclerosingpanencephalitisviruses